Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 6/20 | 0.69 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.69 |
| ▸ | MEN1 | O00255 | 3/20 | 0.69 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.69 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.69 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.69 |
| ▸ | USP2 | O75604 | 2/20 | 0.69 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.69 |
| ▸ | POLB | P06746 | 3/20 | 0.60 |
| ▸ | APEX1 | P27695 | 1/20 | 0.60 |
| ▸ | CASP6 | P55212 | 1/20 | 0.60 |
| ▸ | RAB9A | P51151 | 5/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.58 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.58 |
| ▸ | FGB | P02675 | 1/20 | 0.58 |
| ▸ | THRB | P10828 | 1/20 | 0.58 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.58 |
| ▸ | PPARG | P37231 | 1/20 | 0.58 |
| ▸ | NCOA2 | Q15596 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11756008 | 0.90 | EGFR (0.56) | MAPTALDH1A1MEN1KMT2ATDP1 | |
| SCHEMBL11753706 | 0.90 | EGFR (0.56) | MAPTALDH1A1MEN1KMT2ATDP1 | |
| SCHEMBL11756303 | 0.89 | CYP3A4 (0.55) | MAPTALDH1A1MEN1KMT2ATDP1 | |
| SCHEMBL11754612 | 0.89 | CYP3A4 (0.55) | MAPTALDH1A1MEN1KMT2ATDP1 | |
| SCHEMBL11753985 | 0.89 | CYP3A4 (0.55) | MAPTALDH1A1MEN1KMT2ATDP1 | |
| SCHEMBL5109566 | 0.85 | MAPT (0.79) | MAPTALDH1A1MEN1KMT2ATDP1 | |
| SCHEMBL11210966 | 0.84 | MAPT (0.56) | MAPTALDH1A1MEN1KMT2ATDP1 | |
| 1,4-Dimethoxyanthraquinone SCHEMBL3417221 | 0.83 | MAPT (1.00) | MAPTALDH1A1MEN1KMT2ATDP1 | |
| SCHEMBL5103640 | 0.79 | POLB (0.54) | MAPTMEN1KMT2APOLBAPEX1 | |
| SCHEMBL11577441 | 0.78 | ALDH1A1 (0.68) | MAPTALDH1A1MEN1KMT2ATDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2537186-A1 | USE OF INDANTHRENE COMPOUNDS IN ORGANIC PHOTOVOLTAICS | BASF SE (DE) | 2012-12-26 | — | — | EP | disclosed |
| US-20110203649-A1 | USE OF INDANTHRENE COMPOUNDS IN ORGANIC PHOTOVOLTAICS | BASF SE (DE) | 2011-08-25 | — | — | US | disclosed |
| WO-2011101810-A1 | USE OF INDANTHRENE COMPOUNDS IN ORGANIC PHOTOVOLTAICS | BASF SE (DE) | 2011-08-25 | — | — | WO | disclosed |
| US-4006171-A | FROM NITROANTHRAQUINONE AND HALOGEN | BAYER AKTIENGESELLSCHAFT (DT) | 1977-02-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110203649-A1 | USE OF INDANTHRENE COMPOUNDS IN ORGANIC PHOTOVOLTAICS | ICMT, EPCAM, INF2 | MAPT 266/4885ALDH1A1 1759/4885MEN1 1375/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.